Biotech AI Budget Benchmarks 2026: Mid-Market Spending Data
Data-driven benchmarks on 2026 biotech AI budgets covering percent of R&D spend, mid-cap CoE costs (about $2M), implementation timelines, GPU pricing, and ROI evidence.
Back to Articles
Articles tagged with “drug-discovery-roi”
Measuring AI ROI in Drug Discovery: Key Metrics & Outcomes
Learn how to measure AI ROI in drug discovery beyond cost and time savings. Updated for 2026 with 173+ AI clinical programs, Insilico's Phase IIa results, Recursion-Exscientia merger, and new FDA guidance. Key metrics for scientific outcomes, pipeline productivity, and commercial value.